Clinical trial
Phase II Study of ZD6474 in Advanced NSCLC
NCT00290537 · M.D. Anderson Cancer Center, Other · Terminated
Key facts
| NCT number | NCT00290537 |
|---|---|
| Title | Phase II Study of ZD6474 in Advanced NSCLC |
| Official title | A Phase II Study of ZD6474 Alone and With Chemotherapy in Advanced NSCLC |
| Lead sponsor | M.D. Anderson Cancer Center, Other |
| Collaborators | AstraZeneca Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug |
| Interventions | ZD6474, Carboplatin, Paclitaxel |
| Enrollment | 4 |
| Start date | Jan 1, 2006 |
| Primary completion | Apr 1, 2008 |
| Completion | Apr 1, 2008 |
| First posted | Feb 13, 2006 |
| Last update posted | May 19, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: